twinks albert and birdsim piss and fuck.desi porn
nxxx.desi
xxx sex

Prestige Consumer Healthcare Inc. (NYSE:PBH) Shares Sold by Royce & Associates LP


Royce & Associates LP reduced its position in shares of Prestige Consumer Healthcare Inc. (NYSE:PBHGet Rating) by 5.9% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 63,224 shares of the company’s stock after selling 3,941 shares during the period. Royce & Associates LP owned 0.13% of Prestige Consumer Healthcare worth $3,150,000 at the end of the most recent quarter.

Several other large investors have also modified their holdings of PBH. Advisor Group Holdings Inc. lifted its holdings in shares of Prestige Consumer Healthcare by 10.9% during the 1st quarter. Advisor Group Holdings Inc. now owns 3,694 shares of the company’s stock worth $196,000 after acquiring an additional 363 shares during the period. JPMorgan Chase & Co. lifted its holdings in shares of Prestige Consumer Healthcare by 10.8% during the 1st quarter. JPMorgan Chase & Co. now owns 210,242 shares of the company’s stock worth $11,130,000 after acquiring an additional 20,496 shares during the period. Raymond James & Associates lifted its holdings in shares of Prestige Consumer Healthcare by 84.8% during the 1st quarter. Raymond James & Associates now owns 9,326 shares of the company’s stock worth $494,000 after acquiring an additional 4,279 shares during the period. US Bancorp DE lifted its holdings in shares of Prestige Consumer Healthcare by 67.7% during the 1st quarter. US Bancorp DE now owns 10,237 shares of the company’s stock worth $541,000 after acquiring an additional 4,132 shares during the period. Finally, HighTower Advisors LLC lifted its holdings in shares of Prestige Consumer Healthcare by 6.0% during the 1st quarter. HighTower Advisors LLC now owns 5,791 shares of the company’s stock worth $307,000 after acquiring an additional 330 shares during the period. 99.98% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several research firms recently commented on PBH. Oppenheimer raised their price target on shares of Prestige Consumer Healthcare from $63.00 to $72.00 and gave the company an “outperform” rating in a report on Friday, January 13th. StockNews.com began coverage on shares of Prestige Consumer Healthcare in a report on Wednesday, October 12th. They issued a “buy” rating on the stock. Canaccord Genuity Group began coverage on shares of Prestige Consumer Healthcare in a report on Wednesday, November 16th. They issued a “buy” rating and a $71.00 price target on the stock. Finally, Canaccord Genuity Group began coverage on shares of Prestige Consumer Healthcare in a report on Thursday, November 17th. They issued a “buy” rating and a $71.00 price target on the stock. One research analyst has rated the stock with a hold rating and five have assigned a buy rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $71.00.

Prestige Consumer Healthcare Trading Down 1.2 %

PBH opened at $66.22 on Wednesday. The firm has a market capitalization of $3.28 billion, a P/E ratio of 16.07, a P/E/G ratio of 2.00 and a beta of 0.57. The firm’s 50 day moving average is $62.76 and its 200-day moving average is $57.37. Prestige Consumer Healthcare Inc. has a 52-week low of $48.51 and a 52-week high of $67.45. The company has a quick ratio of 1.29, a current ratio of 2.21 and a debt-to-equity ratio of 0.89.

Prestige Consumer Healthcare (NYSE:PBHGet Rating) last posted its quarterly earnings data on Thursday, November 3rd. The company reported $1.02 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.00 by $0.02. The company had revenue of $289.27 million for the quarter, compared to analyst estimates of $282.93 million. Prestige Consumer Healthcare had a net margin of 18.83% and a return on equity of 12.88%. Analysts expect that Prestige Consumer Healthcare Inc. will post 4.2 EPS for the current fiscal year.

Prestige Consumer Healthcare Profile

(Get Rating)

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.

Featured Stories

Institutional Ownership by Quarter for Prestige Consumer Healthcare (NYSE:PBH)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Before you consider Prestige Consumer Healthcare, you’ll want to hear this.

MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and Prestige Consumer Healthcare wasn’t on the list.

While Prestige Consumer Healthcare currently has a “Moderate Buy” rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Elon Musk’s Next Move

Wondering when you’ll finally be able to invest in SpaceX, StarLink or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

Elon Musk's Next Move Cover



Source link

girlfriends having fun with their favorite toy.amateur girls double dong full insertion.
pornsnake.net
sex tube my golden pussy is not beautiful and.